Six biocidal active substance approvals extended to 2029 because evaluations are delayed — for hydrogen peroxide due to the assessment of the 5-batch analysis, for MIT of developmental neurotoxicity data; folpet loses product-type 7

Commission Implementing Decisions (EU) 2026/2119, 2026/2124, 2026/2127, 2026/2131, 2026/2134 and 2026/2151, published on 25 and 28 September 2026, extend the expiry dates of approvals because the evaluation of renewal applications has been delayed for reasons beyond the applicants’ control: hydrogen peroxide (product-types 1–5) and granulated copper (product-type 8) — to 31 July 2029, K-HDO (product-type 8) — to 30 June 2029, IPBC (product-type 13) — to 31 May 2029, 2-methylisothiazol-3(2H)-one, i.e. MIT (product-type 13), and folpet (product-type 9) — to 31 March 2029.

Source: Decyzja wykonawcza Komisji (UE) 2026/2131 — przedłużenie ważności zatwierdzenia nadtlenku wodoru w grupach produktowych 1–5

Lab-News